Researchers Use New Genetic Mapping Technique to Identify Genes Associated with Macular Degeneration
September 17, 2013
Source: Nature Genetics
There are a number of current and previous BrightFocus-funded researchers who are co-authors of this new study.
Researchers at the University of Michigan pinpointed new regions in two genes that, when defective, can greatly increase the risk of macular degeneration, the leading cause of vision problems in the elderly.
Goncalo Abecasis, a University of Michigan professor and the lead author of the report, said much of the discovery's success is from a new method of gene mapping that uses ancestry-matched controls from existing gene databases – something that had never been done before.
"We showed this new approach could work," said Abecasis from the U-M School of Public Health. The findings will be posted online Sept. 15 in the journal Nature Genetics.
The new approach searched already sequenced individuals with similar ancestry to macular degeneration cases U-M researchers were studying. Matches were then placed in the control group, increasing the ability to pinpoint genetic variants and ultimately leading to the discovery.
Abecasis said he hopes researchers will take the new finding he and his colleagues gleaned and use it to develop new treatments or a cure for macular degeneration. The statistical methods for matching ancestry used in this study could be duplicated in genetic studies of other diseases, potentially opening up new realms of discovery.
Age-related macular degeneration is a leading cause of vision loss for seniors. It is caused by the deterioration of a small, central part of the retina. It affects the ability to read, drive and carry on day-to-day activities. Currently there is no cure.
The University of Michigan has long been conducting genetic research into the causes of macular degeneration and has a large database of patient volunteers recruited at the Kellogg Eye Center.
This study involved 2,335 cases and 789 controls, with most samples originating from the Kellogg Eye Center.
Adapted from the University of Michigan
View all news updates for macular degeneration
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.